LifeMD vs Ro
Neither LifeMD nor Ro has an FDA warning letter on record. No price lines up like for like. They share brand-name semaglutide pen, but Ro's $199 covers the medication only, with a separate membership on top.
To see where both sit among the other sellers, read our best weight-loss injection providers board.
The record
LifeMD / Ro
LifeMD
6.0/10
Ro
7.4/10
Neither LifeMD nor Ro pays us. Links to them earn nothing. Scores: LifeMD 6.0, Ro 7.4. How we are paid
What the record shows
- 01
Neither LifeMD nor Ro has an FDA warning letter on record.
- 02
No price lines up like for like. They share brand-name semaglutide pen, but Ro's $199 covers the medication only, with a separate membership on top.
- 03
Only Ro lists a price for Foundayo (orforglipron) pill.
Prices and terms, product by product
A price is set against the other side only for the same product, and only when both are standing monthly or 4-week rates. Those pairs are compared by yearly cost.
LifeMD
Ro
$348/mo
$4,176 a year
$199/mo
medication only, membership extra; not compared
$448/mo
$5,376 a year
$299/mo
medication only, membership extra; not compared
$298/mo
$3,576 a year
$149/mo
medication only, membership extra; not compared
$149/mo
medication only, membership extra; not compared
Read off each seller’s own pages. LifeMD: October 31, 2026. Ro: October 31, 2026. Every plan and dose we hold is on the full review.
The case for each
The case for LifeMD
6.0/10The record gives LifeMD no edge on this pair.
- Price leaves out medication
The case for Ro
7.4/10- Sells Foundayo (orforglipron) pill, which LifeMD does not price
- Price leaves out medication
- Lowest price covers the medication only, with a separate membership on top
Scores
LifeMD 6.0 · Ro 7.4 out of 10. Six weighted parts.
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
The score is the same formula for every seller. Payment does not enter it. Method
LifeMD vs Ro: questions
Other sellers we are paid by
Affiliate partners outside this pair. Each has its own record and review, scored the same way.
- TrimRx6.4
From $299/mo
Visit site - Direct Meds7.1
From $249/mo
Visit site - SnagRx9.2
From $99/mo
Visit site
Sellers closest to these two
Matched on molecule, form and price. Every pair we list · The register
Brand names on this page are registered marks. Novo Nordisk holds Wegovy®, Ozempic® and Rybelsus®; Eli Lilly holds Zepbound®, Mounjaro® and Foundayo®. Neither company has any tie to GLP Watchdog. Trademarks